Cargando…

Nonspecific Effects of Infant Vaccines Make Children More Resistant to SARS-CoV-2 Infection

A myriad of reasons, or a combination of them, have been alluded to in order to explain the lower susceptibility of children to SARS-CoV-2 infection and the development of severe forms of COVID-19. This document explores an additional factor, still little addressed in the medical literature related...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fonte, Luis, Ginori, María, García, Gissel, Hernández, Yisel, de Armas, Yaxsier, Calderón, Enrique J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777511/ https://www.ncbi.nlm.nih.gov/pubmed/36553302 http://dx.doi.org/10.3390/children9121858

Ejemplares similares

Prevalence of Pneumocystosis in Sub-Saharan Africa and Helminth Immune Modulation
por: Fonte, Luis, et al.
Publicado: (2021)

Overlapping of Pulmonary Fibrosis of Postacute COVID-19 Syndrome and Tuberculosis in the Helminth Coinfection Setting in Sub-Saharan Africa
por: Fonte, Luis, et al.
Publicado: (2022)

Regarding the call to explore the unexpected low severity of COVID-19 in Sub-Saharan Africa
por: Fonte, Luis, et al.
Publicado: (2020)

How to make models more useful
por: Barton, C. Michael, et al.
Publicado: (2022)

COVID-19 Lethality in Sub-Saharan Africa and Helminth Immune Modulation
por: Fonte, Luis, et al.
Publicado: (2020)

Are Older People Really More Susceptible to SARS-CoV-2?
por: Zhang, Shuo, et al.
Publicado: (2022)

Creating more and more new institutions may not make the world safer from pandemics
por: Wenham, Clare
Publicado: (2023)

Can microbiology help to make aviation more sustainable?
por: Segura, Ana, et al.
Publicado: (2022)

Multilocus Genotyping of Pneumocystis jirovecii from Deceased Cuban AIDS Patients Using Formalin-Fixed and Paraffin-Embedded Tissues
por: Friaza, Vicente, et al.
Publicado: (2021)

Genetic and Morphological Identification of Spirometra decipiens in Snakes and Domestic Dog Found in Cuba
por: Morales, Alexander, et al.
Publicado: (2022)

The Safety of Anti-SARS-CoV-2 Vaccines: Vigilance Is Still Required
por: Goldman, Michel
Publicado: (2022)

Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
por: Fraser, Rupsha, et al.
Publicado: (2023)

SARS-CoV-2 Vaccines: Inactivation by Gamma Irradiation for T and B Cell Immunity
por: Mullbacher, Arno, et al.
Publicado: (2020)

Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?
por: Tang, Patrick Chun Hean, et al.
Publicado: (2022)

Broad and nonspecific clinical manifestations of SARS-CoV-2 infection in young infants
por: Long, Sarah S.
Publicado: (2021)

Trust in Vaccines: Why It Takes More than Good Faith
por: Begg, Norman
Publicado: (2013)

Building the infrastructure to make science metrics more scientific
por: Lin, Jennifer, et al.
Publicado: (2017)

In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction
por: Silva-Arrieta, Sandra, et al.
Publicado: (2020)

Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
por: Lippi, Giuseppe, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in liver transplant recipients: We still haven't found what we are looking for
por: Thompson, Marcos A., et al.
Publicado: (2023)

Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?
por: Speeckaert, Reinhart, et al.
Publicado: (2021)

T Cells: Warriors of SARS-CoV-2 Infection
por: de Candia, Paola, et al.
Publicado: (2021)

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
por: Bauer, Lisa, et al.
Publicado: (2022)

Understanding Laboratory Testing for SARS-CoV-2
por: Cheema, Ritu, et al.
Publicado: (2021)

Every scientist is a memory researcher: Suggestions for making research more memorable
por: Madan, Christopher R.
Publicado: (2015)

Rapid deployment of SARS-CoV-2 testing: The CLIAHUB
por: Crawford, Emily D., et al.
Publicado: (2020)

Nano-targeting lessons from the SARS-CoV-2
por: Ribeiro, I.R.S., et al.
Publicado: (2021)

Is Omicron the last SARS-CoV-2 Variant of Concern?
por: Rahimi, Farid, et al.
Publicado: (2022)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
por: Ke, Hanzhong, et al.
Publicado: (2022)

Potential Applications of Plant Biotechnology against SARS-CoV-2
por: Capell, Teresa, et al.
Publicado: (2020)

SARS-CoV-2–A Tough Opponent for the Immune System
por: Nasab, Mahsa Golshani, et al.
Publicado: (2020)

Virus Eradication and Synthetic Biology: Changes with SARS-CoV-2?
por: Tournier, Jean-Nicolas, et al.
Publicado: (2021)

Heme, Heme Oxygenase-1, Statins, and SARS-CoV-2
por: Stevenson, David K., et al.
Publicado: (2023)

Spying on SARS-CoV-2 with Fluorescent Tags and Protease Reporters
por: To, Tsz-Leung, et al.
Publicado: (2023)

SARS-CoV-2 and the next generations: which impact on reproductive tissues?
por: Zupin, Luisa, et al.
Publicado: (2020)

SARS-CoV-2: Cross-scale Insights from Ecology and Evolution
por: Snedden, Celine E., et al.
Publicado: (2021)

Why Does SARS-CoV-2 Infection Induce Autoantibody Production?
por: Macela, Ales, et al.
Publicado: (2021)

The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2
por: Sarkar, Amar, et al.
Publicado: (2021)

Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2
por: Tonk, Miray, et al.
Publicado: (2021)

Targeting SARS-CoV-2 papain-like protease in the postvaccine era
por: Ton, Anh-Tien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_86d4jfasfe1o9rkj7r8oruvom3